Summary
A $100 Million Shadow Economy: The on-chain gray-market peptide industry has experienced a breakout, surging past a $100 million annual run rate in recent months.
Fueled by Viral “Looksmaxxing”: What was once a niche biohacker community has been saturated by a youth-driven TikTok subculture obsessed with physical enhancement.
Decline of Safety Testing: As retail consumers flooded the space, independent chemical safety testing rapidly declined. Buyers are trusting vendor-supplied purity reports that ignore critical sterility risks, and injecting unverified compounds.
The Fentanyl-to-Peptide Pivot: On-chain data reveal that some of these gray-market peptide vendors are Chinese chemical manufacturers who recently pivoted away from supplying fentanyl and amphetamine precursors to transnational drug cartels, in order to capitalize on the hype and decrease their operational risk.
